logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12303547 B1

PDFFull Text
Date of Patent:
May. 20, 2025

Filed:

Nov. 22, 2019

Compound, use, pharmaceutical composition, method of diagnosis, method of treatment, and method of transportation and/or internalization of a compound into eukaryotic cells

Applicant:

Instituto Butantan, São Paulo, BR;

Inventors:

Ana Marisa Chudzinski Tavassi, SãPaulo, BR;

Miryam Paola Alvarez-Flores, Säo Paulo, BR;

Katia Luciano Pereira Morais, Säo Paulo, BR;

Gilles Mourier, Villebon-sur-Yvette, FR;

Denis Servent, Gif sur Yvette, FR;

Assignee:

INSTITUTO BUTANTAN, São Paulo, BR;

Attorney:

McKee, Voorhees & Sease, PLC

Primary Examiner:

Aradhana Sasan

Assistant Examiner:

Jia-Hai Lee

Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/10 (2006.01); A61K 47/60 (2017.01);
U.S. Cl.
CPC ...
A61K 38/17 (2013.01); A61K 38/10 (2013.01); A61K 47/60 (2017.08);
Abstract

The invention pertains to the technical fields of pharmaceutical sciences, immunology, diagnosis and/or treatment of cancer. Specifically, the invention relates to peptides derived from the C-terminal portion of the tick amblyomin-X protein, said peptides being intended for targeting or promoting the internalization of molecular entities into the intracellular domain of eukaryotic or neoplastic cells. The invention also relates to the use of said peptides for modifying other pharmaceutically active ingredients, to a pharmaceutical composition comprising said peptides and to a method of diagnosis, prognosis and/or treatment of cancer or other cell-altering conditions.

Find Patent Forward Citations

Tavassi, Ana Marisa Chudzinski. (2025). Compound, use, pharmaceutical composition, method of diagnosis, method of treatment, and method of transportation and/or internalization of a compound into eukaryotic cells (U.S. Patent No. 12303547). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12303547

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…